EREG and endometrial cancer: Consistent with these experimental findings, high EGFR and HER2 expression was associated with low AR expression in the present endometrial cancer cell line panel, thus suggesting that low AR expression could be a useful surrogate marker for receptor tyrosine kinase activation in endometrial cancer, possibly more useful than ER or PR may be.